---
title: "Machine-learning kcat predictors need system-level validation for reliable ecGEM outputs"
id: "biorxiv-7-beyond-benchmark-accuracy-machine-learning-turnover-number-predictors-require"
canonical_url: "https://medichelpline.com/clinical-feed/biorxiv-7-beyond-benchmark-accuracy-machine-learning-turnover-number-predictors-require"
content_type: "clinical_feed_article"
specialty: "General"
source_name: "bioRxiv (Biomedical Preprints)"
source_url: "https://www.biorxiv.org/content/10.64898/2026.08.28.747816v1?rss=1"
published_at: "2026-09-03T11:54:36.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Machine-learning kcat predictors need system-level validation for reliable ecGEM outputs
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/biorxiv-7-beyond-benchmark-accuracy-machine-learning-turnover-number-predictors-require
- **Specialty:** [General](https://medichelpline.com/clinical-feed/general.md)
- **Primary Source:** bioRxiv (Biomedical Preprints)
- **Source URL:** [Original Journal Publication](https://www.biorxiv.org/content/10.64898/2026.08.28.747816v1?rss=1)
- **Published At:** 2026-09-03T11:54:36.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Enzyme turnover numbers (**kcat**) are critical inputs for kinetic and enzyme-constrained genome-scale metabolic models (**ecGEMs**), but experimentally measured values are sparse, motivating machine-learning (ML) estimation. - The authors benchmarked six contemporary **kcat** predictors on a curated BRENDA-derived dataset and evaluated five of them on an independent EnzyExtract dataset, comparing predictors' reported training data overlap with each benchmark. - Global regression metrics used in typical benchmarks provide a moderate picture: performance on the BRENDA-derived dataset was moderate, but accuracy declined sharply on EnzyExtract, where all predictors reached R2 ≤ 0.20. - Overlap between benchmarks and predictors' training sets was substantially lower for EnzyExtract (exact sequence matches 9–26%) than for the BRENDA-derived dataset (24–78%), but overlap alone did not fully explain differences in generalization. - Predicted **kcat** values were used to parameterize ecGEMs of Saccharomyces cerevisiae and to predict growth across 19 conditions; none of the tool-specific ecGEMs consistently reproduced experimentally observed growth variation. - Benchmark ranking did not predict downstream usefulness: the weakest benchmark performer produced the most accurate growth prediction in glucose minimal medium, while higher-ranked predictors caused larger deviations. - The authors traced poor downstream performance to localized, high-leverage errors: underpredicted turnover numbers for the mitochondrial ADP/ATP carrier limited adenine nucleotide exchange and imposed an apparent cytosolic ATP supply constraint in some ecGEMs. - Relaxing the constraint on the carrier's **kcat** shifted predicted growth toward experimental references, demonstrating that ML-derived parameter errors can change both quantitative predictions and the apparent phenotype inferred by mechanistic models. - The study argues that **application-driven validation** of biological parameter predictors — testing them within the downstream systems they will inform — is necessary beyond standard benchmark metrics. - Data and code supporting the study are available in linked repositories; the authors declare no competing interests.
## Clinical Analysis & Structured Key Points
Enzyme turnover numbers (kcat) are essential for kinetic models and enzyme-constrained genome-scale metabolic models (ecGEMs), but measured values are sparse and therefore increasingly estimated using machine learning (ML). Although these predictors are commonly evaluated by global regression metrics, their practical utility depends on how errors propagate through downstream models. We benchmarked six current kcat predictors on a curated BRENDA-derived dataset and five of them on EnzyExtract. To assess the influence of training-set proximity, we compared each benchmark dataset with the available training data for each predictor. We then used the predicted kcat values to parameterize ecGEMs of Saccharomyces cerevisiae and evaluated growth predictions across 19 conditions. We find that benchmark accuracy is moderate even on the BRENDA-derived dataset and drops sharply on EnzyExtract, where all predictors achieve R2 values of 0.20 or lower. This decline is accompanied by substantially lower overlap between the benchmark and training datasets, with exact sequence matches ranging from 24% to 78% for BRENDA, compared with 9% to 26% for EnzyExtract. However, that overlap alone does not explain differences in generalization across predictors. Moreover, downstream performance is also not explained by benchmark ranking. Across 19 conditions, none of the tool-specific ecGEMs consistently reproduces the experimentally observed variation in growth. In glucose minimal medium, the weakest benchmark performer yields the most accurate growth prediction in the downstream ecGEMs, whereas higher-ranked predictors produce larger deviations in growth. We trace this mismatch to localized errors at high-leverage positions in yeast's metabolic network, where underpredicted mitochondrial ADP/ATP carrier turnover numbers restrict adenine nucleotide exchange and impose an apparent limitation on cytosolic ATP supply. Relaxing this constraint shifts predicted growth toward the experimental reference. Thus, ML-derived kcat values can affect not only quantitative growth predictions but also the phenotype a mechanistic model appears to identify. These results argue for application-driven validation of biological parameter predictors in the downstream systems they are intended to support.
## Related Clinical Research

- [Rising prevalence of single and multiple organ fibrosis in England, 2012–2022](https://medichelpline.com/clinical-feed/bmj-open-2-temporal-trends-in-single-and-multiple-organ-fibrosis-prevalence-and-primary.md)
- [First‑trimester glycolipid and inflammatory markers linked to gestational diabetes risk in rural S](https://medichelpline.com/clinical-feed/bmj-open-11-evaluation-of-the-first-trimester-maternal-glycolipid-profile-on-gestational.md)
- [CoRoPINN: Cognitive Region-Optimized PINNs for More Accurate PDE Solving](https://medichelpline.com/clinical-feed/plos-one-20-coropinn-cognitive-region-optimized-physics-informed-neural-networks.md)
- [Design and testing of FFF-printed PLA honeycomb sandwich panels for flexural strength and mass eff](https://medichelpline.com/clinical-feed/plos-one-1-experimental-investigation-and-multi-response-design-of-fff-printed-pla.md)
- [Generative Neuromorphic Programming of Mammalian Cells Using ERNs and Biomorphic Neural Networks](https://medichelpline.com/clinical-feed/biorxiv-0-generative-neuromorphic-programming-of-mammalian-cells.md)

## Navigation
- [← Back to General Feed](https://medichelpline.com/clinical-feed/general.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.